“Improving BNT162b2 MRNA Vaccine Tolerability Without Efficacy Loss by Pidotimod Supplementation: Pidotimod in SARS-CoV-2 Vaccination”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 14 (1): e2022023. https://doi.org/10.4084/MJHID.2022.023.